The Executive Yuan yesterday approved two bills to govern regenerative medicine that aim to boost development of the field.
Taiwan would reach an important milestone in regenerative medicine development with passage of the regenerative medicine act and the regenerative medicine preparations ordinance, which would allow studies to proceed and treatments to be developed, Deputy Minister of Health and Welfare Victor Wang (王必勝) told reporters at a news conference after a Cabinet meeting.
Regenerative treatments have been used for several conditions, including cancer — by regenerating blood cells — and restoring joint function in soft tissue, Wang said.
Photo: Taipei Times
The draft legislation requires regenerative treatments to undergo human trials, he said.
“However, human trials might be waived if patients’ lives are in danger or in other extenuating circumstances,” he added.
Ministry of Health and Welfare Department of Civil Ethics Director-General Liu Yueh-ping (劉越萍) said that waivers for human trials would only be granted when people seek new treatments after other methods have failed.
The draft regenerative medicine bill stipulates that only government-certified medical institutions can administer such treatments, with individuals or organizations that administer them without permission to face fines of NT$2 million to NT$20 million (US$61,391 to US$613,911).
Non-medical institutions would face fines of NT$2 million to NT$20 million for advertising for the use of regenerative medical treatments, the bill says.
The bill also lists the conditions under which medical institutions could proceed with regenerative medical treatments without first conducting human trials.
People must have a life-threatening or severely debilitating disease, and Taiwan cannot have medication, equipment or technology that meets the need, while medical institutions can offer regenerative medical treatments that have been approved by the ministry before the bill is promulgated, it says.
The bill would also upgrade the status of the Ethical Guidelines Governing the Research of Human Embryos and Embryonic Stem Cell Research to law. The guidelines state that embryos and embryonic stem cells used in regenerative medical studies must not be produced through artificial insemination.
Moreover, embryos or embryonic stem cells acquired for research cannot be used to implant nucleated human ova in cell nuclei of other species, the guidelines say.
Researchers would be banned from acquiring research-use embryos for embryonic stem cells or using them to produce chimeric species that have human germ cells, the guidelines say.
The regenerative medicine preparations ordinance covers treatments that contain genes, cells and their derivatives for human use, including gene therapy, cell therapy and tissue engineering.
Pharmaceutical firms seeking to manufacture or import regenerative treatments must have their facilities inspected and registered, and they must be approved and issued a valid license to manufacture or import the products, the bill says.
Licenses would be valid for five years and can be extended for another five years if an extension is applied for three to six months in advanced and it is approved, the bill says.
To facilitate “compassionate treatment” for people with life-threatening illnesses for which other treatments are not available, the bill authorizes the ministry to approve under certain conditions the use of regenerative products after a phase 2 clinical trial has been completed and the product has been shown to be safe and effective.
Licenses for such products would be valid for five years and cannot be extended.
Both bills have regulations to protect people seeking regenerative treatment or medication.
The ministry has the authority to stop or terminate all or part of a regenerative treatments if a medical provider is facing an unusually high number of liability cases.
An alleged US government plan to encourage Taiwan Semiconductor Manufacturing Co (TSMC) to form a joint venture with Intel to boost US chipmaking would place the Taiwanese foundry giant in a more disadvantageous position than proposed tariffs on imported chips, a semiconductor expert said yesterday. If TSMC forms a joint venture with its US rival, it faces the risk of technology outflow, said Liu Pei-chen (劉佩真), a researcher at the Taiwan Industry Economics Database of the Taiwan Institute of Economic Research. A report by international financial services firm Baird said that Asia semiconductor supply chain talks suggest that the US government would
WANG RELEASED: A police investigation showed that an organized crime group allegedly taught their clients how to pretend to be sick during medical exams Actor Darren Wang (王大陸) and 11 others were released on bail yesterday, after being questioned for allegedly dodging compulsory military service or forging documents to help others avoid serving. Wang, 33, was catapulted into stardom for his role in the coming-of-age film Our Times (我的少女時代). Lately, he has been focusing on developing his entertainment career in China. The New Taipei District Prosecutors’ Office last month began investigating an organized crime group that is allegedly helping men dodge compulsory military service using falsified documents. Police in New Taipei City Yonghe Precinct at the end of last month arrested the main suspect,
Starlux Airlines on Tuesday announced it is to launch new direct flights from Taiwan Taoyuan International Airport to Ontario, California, on June 2. The carrier said it plans to deploy the new-generation Airbus A350 on the Taipei-Ontario route. The Airbus A350 features a total of 306 seats, including four in first class, 26 in business class, 36 in premium economy and 240 in economy. According to Starlux’s initial schedule, four flights would run between Taoyuan and Ontario per week: Monday, Wednesday, Friday and Saturday. Flights are to depart from Taoyuan at 8:05pm and arrive in California at 5:05pm (local time), while return flights
LITTORAL REGIMENTS: The US Marine Corps is transitioning to an ‘island hopping’ strategy to counterattack Beijing’s area denial strategy The US Marine Corps (USMC) has introduced new anti-drone systems to bolster air defense in the Pacific island chain amid growing Chinese military influence in the region, The Telegraph reported on Sunday. The new Marine Air Defense Integrated System (MADIS) Mk 1 is being developed to counter “the growing menace of unmanned aerial systems,” it cited the Marine Corps as saying. China has constructed a powerful defense mechanism in the Pacific Ocean west of the first island chain by deploying weapons such as rockets, submarines and anti-ship missiles — which is part of its anti-access/area denial (A2/AD) strategy against adversaries — the
RSS